Drugs / LianhuaQingWen
LianhuaQingWen
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06355193 | Nov → Dec 2022 | — | Central South University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04433013 | Jul → Dec 2020 | COVID-19 | Nanyang Technological University | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LianhuaQingWen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06355193 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Lianhua Qingwen, a TCM treatment” NCT04433013 ↗ |